1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Incyclix Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer INX-315, Fulvestrant, Abemaciclib - Breast Cancer, Breast Cancer Metastatic | Phase 1 / Phase 2 | Recruiting | Incyclix Bio | 150 | 2023-03-28 | 2026-04-01 |
Breast Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1)
Fulvestrant (1) · abemaciclib (1)
Australia (1) · United States (1)